drugdevelopment.kableintelligence.com Review:

Drug Development Technology - Drug Development Technology is a procurement and reference site providing a one-stop-shop for professionals and decision makers within the global Drugdevelopment industry

  • https://drugdevelopment.kableintelligence.com/projects/exondys-51-eteplirsen-for-the-treatment-of-duchenne-muscular-dystrophy-dmd Exondys 51 (eteplirsen) for the Treatment of Duchenne Muscular Dystrophy (DMD) - Drug Development Technology - Exondys 51 (eteplirsen) is an injectable solution developed by Sarepta Therapeutics.It is indicated for the treatment of Duchenne muscular dystrophy (DMD) and the drug is specially indicated to treat patients with dystrophin protein deficiency.A...
  • https://drugdevelopment.kableintelligence.com/projects/carnexiv-carbamazepine-for-the-treatment-of-certain-seizure-types-in-adults Carnexiv (carbamazepine) for the Treatment of Partial, Generalised Tonic-clonic Seizures in Adults - Drug Development Technology - Carnexiv (carbamazepine) is an injectable formulation developed by Lundbeck for partial, generalised tonic-clonic seizures in adult patients who are unable to temporarily take oral medication.The US Food and Drug Administration (FDA) granted...
  • https://drugdevelopment.kableintelligence.com/projects/dupixent-dupilumab-for-the-treatment-of-atopic-dermatitis Dupixent (dupilumab) for the Treatment of Atopic Dermatitis - Drug Development Technology - Dupixent (dupilumab) is an investigational drug being developed by Sanofi and Regeneron as a treatment for moderate to severe atopic dermatitis in adult patients.The US Food and Drug Administration (FDA) granted breakthrough therapy designation to...
  • https://drugdevelopment.kableintelligence.com/projects/ocrevus-ocrelizumab-for-the-treatment-of-multiple-sclerosis Ocrevus (ocrelizumab) for the Treatment of Multiple Sclerosis - Drug Development Technology - Developed by Genentech, Ocrevus (ocrelizumab) is indicated for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis.The US Food and Drug Administration (FDA) granted breakthrough therapy designation for...
  • https://drugdevelopment.kableintelligence.com/news/news.html Industry News - Drug Development Technology - Stay up to date with the latest industry updates from the global Drugdevelopment industry
  • https://drugdevelopment.kableintelligence.com/news/newseurocine-vaccines-begins-phase-iii-study-of-influenza-vaccine-immunose-flu-5646729 Eurocine Vaccines begins Phase I/II study of influenza vaccine Immunose FLU - Drug Development Technology - Eurocine Vaccines has commenced a phase I/II clinical study of the quadrivalent influenza vaccine candidate Immunose FLU, a novel nose drop formulation based on the company's technology Endocine and inactivated split antigens.
  • https://drugdevelopment.kableintelligence.com/news/newsgilead-reports-results-from-phase-3-studies-of-switching-to-descovy-based-regimens-from-truvada-based-regimens-5647339 Gilead reports results from Phase 3 studies of switching to Descovy-based regimens from Truvada-based regimens - Drug Development Technology - Gilead Sciences has reported 96-week data from a Phase 3 study and 48-week data from two Phase 3b studies analysing the safety and efficacy of switching virologically suppressed HIV-1 infected patients from regimens containing Truvada to regimens...
  • https://drugdevelopment.kableintelligence.com/news/newsfaron-starts-enrolling-for-phase-iii-trial-of-traumakine-to-treat-respiratory-disease-in-japan-5646795 Faron begins enrolment for Phase III trial of Traumakine to treat respiratory disease in Japan - Drug Development Technology - Faron Pharmaceuticals has reported that its Japanese licensing partner Maruishi Pharmaceutical has recruited the first patient in the Phase III pivotal clinical trial for the treatment of acute respiratory distress syndrome (ARDS) with FP-1201-lyo...
  • https://drugdevelopment.kableintelligence.com/news/newstwo-studies-confirm-positive-benefit-risk-profile-of-xarelto-in-treating-vte-5645106 Two studies confirm positive benefit-risk profile of XARELTO in treating VTE - Drug Development Technology - Janssen Pharmaceuticals and its development partner Bayer announced results of two new real-world studies, which confirmed the positive benefit-risk profile of XARELTO (rivaroxaban) in treating venous thromboembolism (VTE), or blood clots, and...
  • https://drugdevelopment.kableintelligence.com/news/newsboston-biomedical-begins-phase-iii-canstem303c-study-of-napabucasin-to-treat-colorectal-cancer-5645034 Boston Biomedical begins Phase III CanStem303C study of napabucasin to treat colorectal cancer - Drug Development Technology - Boston Biomedical has dosed the first patient in CanStem303C, a new global Phase III study investigating napabucasin in combination with standard of care (FOLFIRI) in patients with previously treated metastatic colorectal carcinoma (mCRC).
  • https://drugdevelopment.kableintelligence.com/contractors/indexAtoZ.html A to Z List of Drugdevelopment Contractors - Drug Development Technology - Find leading drugdevelopment companies providing equipment, products and services to the drugdevelopment industry
  • https://drugdevelopment.kableintelligence.com/contractors/delivery/malvern-drug-development/ Malvern Instruments - Biopharmaceutical and Drug Development - Drug Development Technology - Malvern offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.Systems for critical material attribute informationMalvern has a wide range of experience in small...
  • https://drugdevelopment.kableintelligence.com/contractors/regulatory-affairs/pharmaceutical-developmentgroup/ Pharmaceutical Development Group - Pharmaceutical Consultant and FDA Regulatory Strategist - Drug Development Technology - PDG provides pharmaceutical consulting as a regulatory strategist to firms located around the world, and has since 1999.We offer one-stop-shopping to include US FDA NDA compilation and submission, design and execution of toxicology and clinical...
  • https://drugdevelopment.kableintelligence.com/contractors/delivery/systag-systems/ SYSTAG Systems Technik - Automation Systems for Small-Molecule Drug and API Development - Drug Development Technology - SYSTAG provides specialist innovative tools for automating chemical synthesis reactions for the pharmaceutical and fine chemicals industry.From laboratory-scale to mini-pilot, SYSTAG's conceptual and automation solutions include controlled...
  • https://drugdevelopment.kableintelligence.com/contractors/organic/pfanstiehl-pharma/ Pfanstiehl - Injectable and HPLE Carbohydrates for Protein Stabilisation and Optimisation - Drug Development Technology - Pfanstiehl is a manufacturer specialising in scale-up development, custom synthesis, and purification of injectable, high-purity low-endotoxin (HPLE) carbohydrates. It also produces highly potent active pharmaceutical ingredients (API), and...
  • https://drugdevelopment.kableintelligence.com/contractors/delivery/softigel-drugdelivery/ Softigel - Contract Development Services and Drug Delivery Systems - Drug Development Technology - Softigel is Procaps' strategic business unit for contract development services. The company supports healthcare and related businesses that develop, manufacture and commercialise pharmaceutical products.Softgel capsules for the drug...
  • https://drugdevelopment.kableintelligence.com/projects/ Drugdevelopment Industry Projects - Drug Development Technology - The latest innovations and future developments in the Drugdevelopment industry from Drug Development Technology, containing in-depth project information and specifications, and project images
  • https://drugdevelopment.kableintelligence.com/projects/ibrance-palbociclib-for-the-treatment-of-metastatic-breast-cancer/ Ibrance (palbociclib) for the Treatment of Metastatic Breast Cancer - Drug Development Technology - Ibrance (palbociclib) is an oral formulation developed by Pfizer for the treatment of metastatic breast cancer in women with disease progression post endocrine therapy.The new drug application (NDA) for Ibrance was submitted to the US Food and...
  • https://drugdevelopment.kableintelligence.com/contractors/ Drugdevelopment Contractors by Category - Drug Development Technology - Find quality drugdevelopment products, suppliers, manufacturers and exporters by category in our B2B marketplace
  • https://drugdevelopment.kableintelligence.com/products/zetasizer-at-dls Zetasizer AT for DLS - Drug Development Technology - The Zetasizer AT combines Malvern's industry leading Dynamic Light Scattering (DLS) technology with two decades of expertise in design and automation of process interfaces for analytical instrumentation.The Zetasizer AT is a fully-automated...

    Country: 217.147.67.97, Europe, GB

    City: -0.1224 , United Kingdom

  • Hmurra1 - He is over the moon and says he looked for a long time to find something so perfect. Thanks for making me the "favorite friend"

    I bought this for a friend who is trying to live the "backpacking" and "tiny house" lifestyle. He loves coffee, and bought many, many different types of coffee pots/presses/ones that heat with wood and charge cell phones/orgami-type disposable but portable single serving ones---that he can take camping, but none of them packed flat enough or had a perminant nylon filter. I found this and he flipped! He was so ecstatic he tried it right away. He can steep his coffee for as long as he wants to make it stronger or not. He is over the moon and says he looked for a long time to find something so perfect. Thanks for making me the "favorite friend" and for making him so happy! I've thought about getting me one because it's just so neat--and I don't camp!

  • David R. - 2012 Business Not Ready 2/5/13

    Block is aware of serious problems with the 2012 business software. Form 1120s will not advance past the "partnership and Trust sections". It will abruptly shut down. Another bizarre problem is that if you go to the atx file for 2011 or 2012 and right click, it will tell you that this file opens with the 2008 version.I have spent over 16 hours with Block via phone and chat and trying to find a work around. Last week a supervisor told me it is a known problem but has no idea when it will be fixed. Block also will not let a review be posted on it's website that mentions this problem. They have denied 2 of mine with no reason given. Bill Cobb - CEO apparently does not care about his customers or he would have let all who initially contacted for help know instead of letting us spend hours trying to figure it out. Up until this year I would have given 5 stars rating but this year I have purchased a product that was knowingly faulty and Block apparently does not care about it's customers. To sum it up "H&R Block is not ready for the 2012 tax season" regardless of what it's delusional CEO says in his open letter protesting TurBo tax advertisements. Attached is an open letter I sent Bill Cobb - CEO:

  • Christal - It works, don't believe people who say the "peeling" is fake!

    I bought this from the mall for significantly more even though I got a deal. I just purchased the 4 box set on here and it's the same product. (They sell wholesale on their site) Anywho I use this on my face, neck and now stomach due to darkening and stretch marks after pregnancy (as an experiment on my stomach). It does remove dirt, oil and dead skin. I am dark complexioned and can tell it's my skin from the stuff that falls off, also my skin is left squeaky clean afterwards. Another way I can tell it works is because less skin comes off after you start using it, so don't believe the wannabe at home scientists that say it isn't really peeling your skin off!

  • Amazon Customer - Beware if you are concerned about your privacy...

    I had high expectations for this game. My kids loved Just Dance 2014 and requested 2015 from Santa this year...After getting everything all set up and the PS4 camera positioned, I noticed that no matter what my kids did, the camera would not recognize them at the minimum 5ft position that the game states it needs to recognize players. We spent an hour changing the lighting and camera position and I finally got it to recognize my kids at a lower position on the TV stand but then it wouldn't recognize me...